Altium Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-66,000
| Closed | -$2.25M | – | 127 |
|
|
2022
Q1 | $2.25M | Sell |
66,000
-60,000
| -48% | -$2.04M | 0.75% | 46 |
|
|
2021
Q4 | $4.87M | Sell |
126,000
-59,000
| -32% | -$2.28M | 1.34% | 25 |
|
|
2021
Q3 | $9.99M | Buy |
185,000
+91,884
| +99% | +$4.96M | 2.62% | 3 |
|
|
2021
Q2 | $3.11M | Buy |
93,116
+48,103
| +107% | +$1.61M | 0.72% | 59 |
|
|
2021
Q1 | $927K | Sell |
45,013
-194,507
| -81% | -$4.01M | 0.26% | 112 |
|
|
2020
Q4 | $4.2M | Buy |
+239,520
| New | +$4.2M | 1.57% | 19 |
|